Synthesis and characterization of a 11C-labelled derivative of S12968:: An attempt to image in vivo brain calcium channels

被引:10
作者
Dolle, F
Valette, H
Hinnen, F
Fuseau, C
Peglion, JL
Crouzel, C
机构
[1] CEA, Serv Hosp Frederic Joliot, Dept Rech Med, F-91406 Orsay, France
[2] Inst Rech Servier, F-92150 Suresnes, France
关键词
1,4-dihydropyridine; calcium channel; S12968; carbon-11; biodistribution; lipophilicity;
D O I
10.1016/S0969-8051(97)00211-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
[C-11]S11568 (3-ethyl 5-methyl 2-[2(2-aminoethoxy)ethoxymethyl]-4-(2,3 -dichlorophenyl)-6 methyl 1,4-dihydropyridine-3,5-dicarboxylate) is a powerful ligand for the visualization of the cardiac calcium channel in vivo using PET. The aim of the present study was to synthesize a lipophilic, nonionized derivative of S11568 to facilitate its penetration into the brain. To increase the lipophilicity and to remove simultaneously the ionic nature of our ligand, the N-tert-butoxycarbonyl (N-Boc) derivative of S11568 was synthesized. An IC50 value of 1.7 nM for this derivative confirmed that both the affinity and selectivity for the calcium channel was unaltered by this chemical modification (S11568 with IC50 value of 9.9 nM). The biologically more active enantiomer of S11568, the levogyre isomer S12968, was labelled with C-11 using [C-11]iodomethane. The lipophilicity of the N-Boc derivative-was increased by a factor of three to four when compared to the parent compound las determined by the measurement of the octanol/buffer partition coefficients). In vivo, this derivative slightly crosses the blood-brain barrier, as demonstrated by a 4-fold increase (with respect to the parent compound S12968) of the radioactivity in the brain using the C-11-labelled N-Boc S12968. This uptake remained too low to be suitable for imaging calcium channels. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:339 / 342
页数:4
相关论文
共 20 条
[1]  
CROUZEL C, 1987, APPL RADIAT ISOTOPES, V38, P601
[2]   Synthesis of two optically active calcium channel antagonists labelled with carbon-11 for in vivo cardiac PET imaging [J].
Dolle, F ;
Hinnen, F ;
Valette, H ;
Fuseau, C ;
Duval, R ;
Peglion, JL ;
Crouzel, C .
BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (04) :749-764
[3]   1,4-DIHYDROPYRIDINES - EFFECTS OF CHIRALITY AND CONFORMATION ON THE CALCIUM-ANTAGONIST AND CALCIUM AGONIST ACTIVITIES [J].
GOLDMANN, S ;
STOLTEFUSS, J .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1991, 30 (12) :1559-1578
[4]   INTERACTION OF 1,4 DIHYDROPYRIDINE CALCIUM-CHANNEL ANTAGONISTS WITH BIOLOGICAL-MEMBRANES - LIPID BILAYER PARTITIONING COULD OCCUR BEFORE DRUG-BINDING TO RECEPTORS [J].
HERBETTE, LG ;
VANTERVE, YMH ;
RHODES, DG .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1989, 21 (02) :187-201
[5]   REEVALUATING EQUILIBRIUM AND KINETIC BINDING PARAMETERS FOR LIPOPHILIC DRUGS BASED ON A STRUCTURAL MODEL FOR DRUG-INTERACTION WITH BIOLOGICAL-MEMBRANES [J].
MASON, RP ;
RHODES, DG ;
HERBETTE, LG .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (03) :869-877
[6]  
PARDRIDGE WM, 1991, PEPTIDE DRUG DELIVER, P52
[7]  
PEGLION JL, 1994, P 10 INT S MED CHEM, P255
[8]  
PEGLION JL, Patent No. 8942390
[9]  
PEGLION JL, Patent No. 4870090
[10]  
PEGLION JL, Patent No. 88041460